- Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
- Prime Medicine to Participate in Upcoming Investor Conferences
- Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Prime Medicine Announces Pricing of Upsized Public Offering
- Prime Medicine Announces Proposed Public Offering of Common Stock
- Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
- Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
- Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Prime Medicine to Present at Upcoming Investor Conferences
More ▼
Key statistics
On Thursday, Prime Medicine Inc (PRME:NMQ) closed at 7.00, 26.35% above the 52 week low of 5.54 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.83 |
---|---|
High | 7.06 |
Low | 6.71 |
Bid | 6.76 |
Offer | 7.06 |
Previous close | 6.76 |
Average volume | 481.17k |
---|---|
Shares outstanding | 119.94m |
Free float | 66.32m |
P/E (TTM) | -- |
Market cap | 810.79m USD |
EPS (TTM) | -2.17 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼